ENCell Co (XKRX:456070) ROCE % : -37.55% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is ENCell Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ENCell Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -37.55%.

ENCell Co ROCE % Historical Data

The historical data trend for ENCell Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co ROCE % Chart

ENCell Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

-212.24

-708.88

-28.99

-31.36

ENCell Co Quarterly Data
	Dec20	Dec21	Dec22	Dec23	Mar24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial			-	-115.97	-28.22	-33.95	-37.55

ENCell Co ROCE % Calculation

ENCell Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-14787.65	/	( ( (43981.151 - 2742.451)	+	(55745.014 - 2688.729) )	/ 2 )
	=	-14787.65	/	( (41238.7	+	53056.285)	/ 2 )
	=	-14787.65	/	47147.4925
	=	-31.36 %

ENCell Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-20348.944	/	( ( (58179.858 - 2850.443)	+	(55745.014 - 2688.729) )	/ 2 )
	=	-20348.944	/	( ( 55329.415	+	53056.285 )	/ 2 )
	=	-20348.944	/	54192.85
	=	-37.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

ENCell Co (XKRX:456070) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ENCell Co ROCE % Related Terms

Thank you for viewing the detailed overview of ENCell Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR

Website

http://www.encellinc.com

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines